We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Showcases SAW-48 Automated Nucleic Acid Workstation

By LabMedica International staff writers
Posted on 23 May 2023
Print article
Image: Bioperfectus is a bronze sponsor of the 2023 WordLab-EuroMedLab Congress (Photo courtesy of Bioperfectus)
Image: Bioperfectus is a bronze sponsor of the 2023 WordLab-EuroMedLab Congress (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is highlighting its comprehensive range of laboratory solutions that are designed to address the diagnostic needs of laboratories at this year's WorldLab-EuroMedLab. As a bronze sponsor of the Congress, Bioperfectus is welcoming visitors at the La Nuvola Convention Center in Rome to its booth, ready to present its full range of diagnostic solutions to enhance the efficiency and quality of healthcare services.

Bioperfectus is showcasing the SAW-48 automated nucleic acid extraction workstation, an in-vitro diagnostic medical device that combines sample loading, nucleic acid purification, and PCR setup functions (PCR master mix preparation and nucleic acid pipetting) into one instrument. The SAW-48 offers the same basic functions as the SAW-96 but in a smaller and lighter form factor. Also on display at the booth is the SSNP-2000B nucleic acid extraction system, a laboratory medical device that integrates state-of-the-art technologies to enable automatic nucleic acid extraction of up to 32 samples at a time.

In addition, Bioperfectus is highlighting the SSNP-A6 nucleic acid extraction system, an in-vitro diagnostic medical device that leverages cutting-edge mechanical, electronic, and software technologies to facilitate the automated extraction of nucleic acids from samples. Visitors to the Bioperfectus booth will have the opportunity to experience the STC-96A Plus Real-Time PCR system, a highly flexible, efficient, and reliable instrument that marks a breakthrough in real-time PCR analysis of gene expression and genetic variation. The STC-96A allows users to perform two different PCR assays on a single instrument with separate-controlled programs, offering enhanced versatility. BioPerfectus is also presenting its diagnostic solutions for the detection of respiratory and gastrointestinal infections, cervical cancer screening, as well as vector-borne and zoonotic diseases.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Calprotectin Assay
Fecal Calprotectin ELISA
New
Creatine Kinase-MB Assay
CK-MB Test

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.